183 related articles for article (PubMed ID: 10893001)
1. Inhibition of cell growth and Epstein-Barr virus reactivation by CD40 stimulation in Epstein-Barr virus-transformed B cells.
Fukuda M; Satoh TA; Takanashi M; Hirai K; Ohnishi E; Sairenji T
Viral Immunol; 2000; 13(2):215-29. PubMed ID: 10893001
[TBL] [Abstract][Full Text] [Related]
2. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
3. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
Han H; Nomura T; Honjo T; Tsubata T
Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
Martin HJ; Lee JM; Walls D; Hayward SD
J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines.
Pokrovskaja K; Ehlin-Henriksson B; Kiss C; Challa A; Gordon J; Gogolak P; Klein G; Szekely L
Int J Cancer; 2002 Jun; 99(5):705-12. PubMed ID: 12115504
[TBL] [Abstract][Full Text] [Related]
6. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
[TBL] [Abstract][Full Text] [Related]
7. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the cyclin-dependent kinase inhibitor p27Kip1 in negative signaling through the antigen-receptor of B lymphocytes.
Han H; Nomura T; Honjo T; Tsubata T
Leukemia; 1997 Apr; 11 Suppl 3():367-9. PubMed ID: 9209392
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival.
Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S
J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency.
Moser JM; Upton JW; Gray KS; Speck SH
J Virol; 2005 Apr; 79(8):5227-31. PubMed ID: 15795307
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells.
Cannell EJ; Farrell PJ; Sinclair AJ
Oncogene; 1996 Oct; 13(7):1413-21. PubMed ID: 8875979
[TBL] [Abstract][Full Text] [Related]
12. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
[TBL] [Abstract][Full Text] [Related]
13. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes.
Pomponi F; Cariati R; Zancai P; De Paoli P; Rizzo S; Tedeschi RM; Pivetta B; De Vita S; Boiocchi M; Dolcetti R
Blood; 1996 Oct; 88(8):3147-59. PubMed ID: 8874215
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
Liu X; Cohen JI
J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
[TBL] [Abstract][Full Text] [Related]
15. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
Kelly K; Knox KA
Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression.
Fu Z; Cannon MJ
J Virol; 2000 Jul; 74(14):6675-9. PubMed ID: 10864684
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R
Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049
[TBL] [Abstract][Full Text] [Related]
18. hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
Terrin L; Dolcetti R; Corradini I; Indraccolo S; Dal Col J; Bertorelle R; Bonaldi L; Esposito G; De Rossi A
Int J Cancer; 2007 Aug; 121(3):576-87. PubMed ID: 17417773
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.
Imadome K; Shirakata M; Shimizu N; Nonoyama S; Yamanashi Y
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7836-40. PubMed ID: 12805559
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus Lytic Reactivation Activates B Cells Polyclonally and Induces Activation-Induced Cytidine Deaminase Expression: A Mechanism Underlying Autoimmunity and Its Contribution to Graves' Disease.
Nagata K; Kumata K; Nakayama Y; Satoh Y; Sugihara H; Hara S; Matsushita M; Kuwamoto S; Kato M; Murakami I; Hayashi K
Viral Immunol; 2017 Apr; 30(3):240-249. PubMed ID: 28333576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
